Significant Ownership of MPM BioImpact LLC

Signature - Title
/s/ Christopher Wolf - Chief Financial Officer
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by MPM BioImpact LLC.

Notify me when MPM BioImpact LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of MPM BioImpact LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CNTX Context Therapeutics Inc. Common Stock, par value $0.001 per share 16% $14,705,882 14,705,882 MPM BioImpact LLC 31 Dec 2024
CMPX Compass Therapeutics, Inc. Common Stock, par value $0.001 per share 4.1% $15,180,764 -$7,952,556 5,622,505 -34% MPM BioImpact LLC 30 Jun 2025

Schedules 13D/G Reported by MPM BioImpact LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.